Gastrointestinal Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Gastrointestinal Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Gastrointestinal Therapeutics industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Gastrointestinal Therapeutics 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Gastrointestinal Therapeutics worldwide and market share by regions, with company and product introduction, position in the Gastrointestinal Therapeutics market
Market status and development trend of Gastrointestinal Therapeutics by types and applications
Cost and profit status of Gastrointestinal Therapeutics, and marketing status
Market growth drivers and challenges
The report segments the global Gastrointestinal Therapeutics market as:
Global Gastrointestinal Therapeutics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Gastrointestinal Therapeutics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Tablets
Injection
Global Gastrointestinal Therapeutics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
IBD
Irritable Bowel Syndrome (IBS)
Other
Global Gastrointestinal Therapeutics Market: Manufacturers Segment Analysis (Company and Product introduction, Gastrointestinal Therapeutics Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
AbbVie
Allergan
Takeda
Novartis
Pfizer
GlaxoSmithKline
Merck
UCB (Belgium)
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Eisai
Shire Pharmaceuticals
Ferring Pharmaceuticals
Kyowa Hakko Kirin
Salix Pharmaceuticals
Ono Pharmaceutical
TSD Japan
RedHill Biopharma
Kaken Pharmaceutical
Amgen
Synergy Pharmaceuticals
Ajinomoto
Kissei Pharmaceutical
Hutchison Medi Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Gastrointestinal Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Gastrointestinal Therapeutics industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Gastrointestinal Therapeutics 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Gastrointestinal Therapeutics worldwide and market share by regions, with company and product introduction, position in the Gastrointestinal Therapeutics market
Market status and development trend of Gastrointestinal Therapeutics by types and applications
Cost and profit status of Gastrointestinal Therapeutics, and marketing status
Market growth drivers and challenges
The report segments the global Gastrointestinal Therapeutics market as:
Global Gastrointestinal Therapeutics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Gastrointestinal Therapeutics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Tablets
Injection
Global Gastrointestinal Therapeutics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
IBD
Irritable Bowel Syndrome (IBS)
Other
Global Gastrointestinal Therapeutics Market: Manufacturers Segment Analysis (Company and Product introduction, Gastrointestinal Therapeutics Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
AbbVie
Allergan
Takeda
Novartis
Pfizer
GlaxoSmithKline
Merck
UCB (Belgium)
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Eisai
Shire Pharmaceuticals
Ferring Pharmaceuticals
Kyowa Hakko Kirin
Salix Pharmaceuticals
Ono Pharmaceutical
TSD Japan
RedHill Biopharma
Kaken Pharmaceutical
Amgen
Synergy Pharmaceuticals
Ajinomoto
Kissei Pharmaceutical
Hutchison Medi Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GASTROINTESTINAL THERAPEUTICS
1.1 Definition of Gastrointestinal Therapeutics in This Report
1.2 Commercial Types of Gastrointestinal Therapeutics
1.2.1 Tablets
1.2.2 Injection
1.3 Downstream Application of Gastrointestinal Therapeutics
1.3.1 IBD
1.3.2 Irritable Bowel Syndrome (IBS)
1.3.3 Other
1.4 Development History of Gastrointestinal Therapeutics
1.5 Market Status and Trend of Gastrointestinal Therapeutics 2013-2023
1.5.1 Global Gastrointestinal Therapeutics Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Therapeutics Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gastrointestinal Therapeutics 2013-2017
2.2 Sales Market of Gastrointestinal Therapeutics by Regions
2.2.1 Sales Volume of Gastrointestinal Therapeutics by Regions
2.2.2 Sales Value of Gastrointestinal Therapeutics by Regions
2.3 Production Market of Gastrointestinal Therapeutics by Regions
2.4 Global Market Forecast of Gastrointestinal Therapeutics 2018-2023
2.4.1 Global Market Forecast of Gastrointestinal Therapeutics 2018-2023
2.4.2 Market Forecast of Gastrointestinal Therapeutics by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gastrointestinal Therapeutics by Types
3.2 Sales Value of Gastrointestinal Therapeutics by Types
3.3 Market Forecast of Gastrointestinal Therapeutics by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gastrointestinal Therapeutics by Downstream Industry
4.2 Global Market Forecast of Gastrointestinal Therapeutics by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gastrointestinal Therapeutics Market Status by Countries
5.1.1 North America Gastrointestinal Therapeutics Sales by Countries (2013-2017)
5.1.2 North America Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
5.1.3 United States Gastrointestinal Therapeutics Market Status (2013-2017)
5.1.4 Canada Gastrointestinal Therapeutics Market Status (2013-2017)
5.1.5 Mexico Gastrointestinal Therapeutics Market Status (2013-2017)
5.2 North America Gastrointestinal Therapeutics Market Status by Manufacturers
5.3 North America Gastrointestinal Therapeutics Market Status by Type (2013-2017)
5.3.1 North America Gastrointestinal Therapeutics Sales by Type (2013-2017)
5.3.2 North America Gastrointestinal Therapeutics Revenue by Type (2013-2017)
5.4 North America Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gastrointestinal Therapeutics Market Status by Countries
6.1.1 Europe Gastrointestinal Therapeutics Sales by Countries (2013-2017)
6.1.2 Europe Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
6.1.3 Germany Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.4 UK Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.5 France Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.6 Italy Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.7 Russia Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.8 Spain Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.9 Benelux Gastrointestinal Therapeutics Market Status (2013-2017)
6.2 Europe Gastrointestinal Therapeutics Market Status by Manufacturers
6.3 Europe Gastrointestinal Therapeutics Market Status by Type (2013-2017)
6.3.1 Europe Gastrointestinal Therapeutics Sales by Type (2013-2017)
6.3.2 Europe Gastrointestinal Therapeutics Revenue by Type (2013-2017)
6.4 Europe Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gastrointestinal Therapeutics Market Status by Countries
7.1.1 Asia Pacific Gastrointestinal Therapeutics Sales by Countries (2013-2017)
7.1.2 Asia Pacific Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
7.1.3 China Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.4 Japan Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.5 India Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.6 Southeast Asia Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.7 Australia Gastrointestinal Therapeutics Market Status (2013-2017)
7.2 Asia Pacific Gastrointestinal Therapeutics Market Status by Manufacturers
7.3 Asia Pacific Gastrointestinal Therapeutics Market Status by Type (2013-2017)
7.3.1 Asia Pacific Gastrointestinal Therapeutics Sales by Type (2013-2017)
7.3.2 Asia Pacific Gastrointestinal Therapeutics Revenue by Type (2013-2017)
7.4 Asia Pacific Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gastrointestinal Therapeutics Market Status by Countries
8.1.1 Latin America Gastrointestinal Therapeutics Sales by Countries (2013-2017)
8.1.2 Latin America Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
8.1.3 Brazil Gastrointestinal Therapeutics Market Status (2013-2017)
8.1.4 Argentina Gastrointestinal Therapeutics Market Status (2013-2017)
8.1.5 Colombia Gastrointestinal Therapeutics Market Status (2013-2017)
8.2 Latin America Gastrointestinal Therapeutics Market Status by Manufacturers
8.3 Latin America Gastrointestinal Therapeutics Market Status by Type (2013-2017)
8.3.1 Latin America Gastrointestinal Therapeutics Sales by Type (2013-2017)
8.3.2 Latin America Gastrointestinal Therapeutics Revenue by Type (2013-2017)
8.4 Latin America Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gastrointestinal Therapeutics Market Status by Countries
9.1.1 Middle East and Africa Gastrointestinal Therapeutics Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
9.1.3 Middle East Gastrointestinal Therapeutics Market Status (2013-2017)
9.1.4 Africa Gastrointestinal Therapeutics Market Status (2013-2017)
9.2 Middle East and Africa Gastrointestinal Therapeutics Market Status by Manufacturers
9.3 Middle East and Africa Gastrointestinal Therapeutics Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Gastrointestinal Therapeutics Sales by Type (2013-2017)
9.3.2 Middle East and Africa Gastrointestinal Therapeutics Revenue by Type (2013-2017)
9.4 Middle East and Africa Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL THERAPEUTICS
10.1 Global Economy Situation and Trend Overview
10.2 Gastrointestinal Therapeutics Downstream Industry Situation and Trend Overview
CHAPTER 11 GASTROINTESTINAL THERAPEUTICS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gastrointestinal Therapeutics by Major Manufacturers
11.2 Production Value of Gastrointestinal Therapeutics by Major Manufacturers
11.3 Basic Information of Gastrointestinal Therapeutics by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gastrointestinal Therapeutics Major Manufacturer
11.3.2 Employees and Revenue Level of Gastrointestinal Therapeutics Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GASTROINTESTINAL THERAPEUTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Gastrointestinal Therapeutics Product
12.1.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 AbbVie
12.2.1 Company profile
12.2.2 Representative Gastrointestinal Therapeutics Product
12.2.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AbbVie
12.3 Allergan
12.3.1 Company profile
12.3.2 Representative Gastrointestinal Therapeutics Product
12.3.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Allergan
12.4 Takeda
12.4.1 Company profile
12.4.2 Representative Gastrointestinal Therapeutics Product
12.4.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Takeda
12.5 Novartis
12.5.1 Company profile
12.5.2 Representative Gastrointestinal Therapeutics Product
12.5.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Novartis
12.6 Pfizer
12.6.1 Company profile
12.6.2 Representative Gastrointestinal Therapeutics Product
12.6.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer
12.7 GlaxoSmithKline
12.7.1 Company profile
12.7.2 Representative Gastrointestinal Therapeutics Product
12.7.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
12.8 Merck
12.8.1 Company profile
12.8.2 Representative Gastrointestinal Therapeutics Product
12.8.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Merck
12.9 UCB (Belgium)
12.9.1 Company profile
12.9.2 Representative Gastrointestinal Therapeutics Product
12.9.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of UCB (Belgium)
12.10 F. Hoffmann-La Roche
12.10.1 Company profile
12.10.2 Representative Gastrointestinal Therapeutics Product
12.10.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
12.11 Eli Lilly
12.11.1 Company profile
12.11.2 Representative Gastrointestinal Therapeutics Product
12.11.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eli Lilly
12.12 AstraZeneca
12.12.1 Company profile
12.12.2 Representative Gastrointestinal Therapeutics Product
12.12.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca
12.13 Procter & Gamble
12.13.1 Company profile
12.13.2 Representative Gastrointestinal Therapeutics Product
12.13.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Procter & Gamble
12.14 Eisai
12.14.1 Company profile
12.14.2 Representative Gastrointestinal Therapeutics Product
12.14.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eisai
12.15 Shire Pharmaceuticals
12.15.1 Company profile
12.15.2 Representative Gastrointestinal Therapeutics Product
12.15.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Shire Pharmaceuticals
12.16 Ferring Pharmaceuticals
12.17 Kyowa Hakko Kirin
12.18 Salix Pharmaceuticals
12.19 Ono Pharmaceutical
12.20 TSD Japan
12.21 RedHill Biopharma
12.22 Kaken Pharmaceutical
12.23 Amgen
12.24 Synergy Pharmaceuticals
12.25 Ajinomoto
12.26 Kissei Pharmaceutical
12.27 Hutchison Medi Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL THERAPEUTICS
13.1 Industry Chain of Gastrointestinal Therapeutics
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL THERAPEUTICS
14.1 Cost Structure Analysis of Gastrointestinal Therapeutics
14.2 Raw Materials Cost Analysis of Gastrointestinal Therapeutics
14.3 Labor Cost Analysis of Gastrointestinal Therapeutics
14.4 Manufacturing Expenses Analysis of Gastrointestinal Therapeutics
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Gastrointestinal Therapeutics in This Report
1.2 Commercial Types of Gastrointestinal Therapeutics
1.2.1 Tablets
1.2.2 Injection
1.3 Downstream Application of Gastrointestinal Therapeutics
1.3.1 IBD
1.3.2 Irritable Bowel Syndrome (IBS)
1.3.3 Other
1.4 Development History of Gastrointestinal Therapeutics
1.5 Market Status and Trend of Gastrointestinal Therapeutics 2013-2023
1.5.1 Global Gastrointestinal Therapeutics Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Therapeutics Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gastrointestinal Therapeutics 2013-2017
2.2 Sales Market of Gastrointestinal Therapeutics by Regions
2.2.1 Sales Volume of Gastrointestinal Therapeutics by Regions
2.2.2 Sales Value of Gastrointestinal Therapeutics by Regions
2.3 Production Market of Gastrointestinal Therapeutics by Regions
2.4 Global Market Forecast of Gastrointestinal Therapeutics 2018-2023
2.4.1 Global Market Forecast of Gastrointestinal Therapeutics 2018-2023
2.4.2 Market Forecast of Gastrointestinal Therapeutics by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gastrointestinal Therapeutics by Types
3.2 Sales Value of Gastrointestinal Therapeutics by Types
3.3 Market Forecast of Gastrointestinal Therapeutics by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gastrointestinal Therapeutics by Downstream Industry
4.2 Global Market Forecast of Gastrointestinal Therapeutics by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gastrointestinal Therapeutics Market Status by Countries
5.1.1 North America Gastrointestinal Therapeutics Sales by Countries (2013-2017)
5.1.2 North America Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
5.1.3 United States Gastrointestinal Therapeutics Market Status (2013-2017)
5.1.4 Canada Gastrointestinal Therapeutics Market Status (2013-2017)
5.1.5 Mexico Gastrointestinal Therapeutics Market Status (2013-2017)
5.2 North America Gastrointestinal Therapeutics Market Status by Manufacturers
5.3 North America Gastrointestinal Therapeutics Market Status by Type (2013-2017)
5.3.1 North America Gastrointestinal Therapeutics Sales by Type (2013-2017)
5.3.2 North America Gastrointestinal Therapeutics Revenue by Type (2013-2017)
5.4 North America Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gastrointestinal Therapeutics Market Status by Countries
6.1.1 Europe Gastrointestinal Therapeutics Sales by Countries (2013-2017)
6.1.2 Europe Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
6.1.3 Germany Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.4 UK Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.5 France Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.6 Italy Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.7 Russia Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.8 Spain Gastrointestinal Therapeutics Market Status (2013-2017)
6.1.9 Benelux Gastrointestinal Therapeutics Market Status (2013-2017)
6.2 Europe Gastrointestinal Therapeutics Market Status by Manufacturers
6.3 Europe Gastrointestinal Therapeutics Market Status by Type (2013-2017)
6.3.1 Europe Gastrointestinal Therapeutics Sales by Type (2013-2017)
6.3.2 Europe Gastrointestinal Therapeutics Revenue by Type (2013-2017)
6.4 Europe Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gastrointestinal Therapeutics Market Status by Countries
7.1.1 Asia Pacific Gastrointestinal Therapeutics Sales by Countries (2013-2017)
7.1.2 Asia Pacific Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
7.1.3 China Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.4 Japan Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.5 India Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.6 Southeast Asia Gastrointestinal Therapeutics Market Status (2013-2017)
7.1.7 Australia Gastrointestinal Therapeutics Market Status (2013-2017)
7.2 Asia Pacific Gastrointestinal Therapeutics Market Status by Manufacturers
7.3 Asia Pacific Gastrointestinal Therapeutics Market Status by Type (2013-2017)
7.3.1 Asia Pacific Gastrointestinal Therapeutics Sales by Type (2013-2017)
7.3.2 Asia Pacific Gastrointestinal Therapeutics Revenue by Type (2013-2017)
7.4 Asia Pacific Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gastrointestinal Therapeutics Market Status by Countries
8.1.1 Latin America Gastrointestinal Therapeutics Sales by Countries (2013-2017)
8.1.2 Latin America Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
8.1.3 Brazil Gastrointestinal Therapeutics Market Status (2013-2017)
8.1.4 Argentina Gastrointestinal Therapeutics Market Status (2013-2017)
8.1.5 Colombia Gastrointestinal Therapeutics Market Status (2013-2017)
8.2 Latin America Gastrointestinal Therapeutics Market Status by Manufacturers
8.3 Latin America Gastrointestinal Therapeutics Market Status by Type (2013-2017)
8.3.1 Latin America Gastrointestinal Therapeutics Sales by Type (2013-2017)
8.3.2 Latin America Gastrointestinal Therapeutics Revenue by Type (2013-2017)
8.4 Latin America Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gastrointestinal Therapeutics Market Status by Countries
9.1.1 Middle East and Africa Gastrointestinal Therapeutics Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Gastrointestinal Therapeutics Revenue by Countries (2013-2017)
9.1.3 Middle East Gastrointestinal Therapeutics Market Status (2013-2017)
9.1.4 Africa Gastrointestinal Therapeutics Market Status (2013-2017)
9.2 Middle East and Africa Gastrointestinal Therapeutics Market Status by Manufacturers
9.3 Middle East and Africa Gastrointestinal Therapeutics Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Gastrointestinal Therapeutics Sales by Type (2013-2017)
9.3.2 Middle East and Africa Gastrointestinal Therapeutics Revenue by Type (2013-2017)
9.4 Middle East and Africa Gastrointestinal Therapeutics Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL THERAPEUTICS
10.1 Global Economy Situation and Trend Overview
10.2 Gastrointestinal Therapeutics Downstream Industry Situation and Trend Overview
CHAPTER 11 GASTROINTESTINAL THERAPEUTICS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gastrointestinal Therapeutics by Major Manufacturers
11.2 Production Value of Gastrointestinal Therapeutics by Major Manufacturers
11.3 Basic Information of Gastrointestinal Therapeutics by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gastrointestinal Therapeutics Major Manufacturer
11.3.2 Employees and Revenue Level of Gastrointestinal Therapeutics Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GASTROINTESTINAL THERAPEUTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Gastrointestinal Therapeutics Product
12.1.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 AbbVie
12.2.1 Company profile
12.2.2 Representative Gastrointestinal Therapeutics Product
12.2.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AbbVie
12.3 Allergan
12.3.1 Company profile
12.3.2 Representative Gastrointestinal Therapeutics Product
12.3.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Allergan
12.4 Takeda
12.4.1 Company profile
12.4.2 Representative Gastrointestinal Therapeutics Product
12.4.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Takeda
12.5 Novartis
12.5.1 Company profile
12.5.2 Representative Gastrointestinal Therapeutics Product
12.5.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Novartis
12.6 Pfizer
12.6.1 Company profile
12.6.2 Representative Gastrointestinal Therapeutics Product
12.6.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer
12.7 GlaxoSmithKline
12.7.1 Company profile
12.7.2 Representative Gastrointestinal Therapeutics Product
12.7.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
12.8 Merck
12.8.1 Company profile
12.8.2 Representative Gastrointestinal Therapeutics Product
12.8.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Merck
12.9 UCB (Belgium)
12.9.1 Company profile
12.9.2 Representative Gastrointestinal Therapeutics Product
12.9.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of UCB (Belgium)
12.10 F. Hoffmann-La Roche
12.10.1 Company profile
12.10.2 Representative Gastrointestinal Therapeutics Product
12.10.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
12.11 Eli Lilly
12.11.1 Company profile
12.11.2 Representative Gastrointestinal Therapeutics Product
12.11.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eli Lilly
12.12 AstraZeneca
12.12.1 Company profile
12.12.2 Representative Gastrointestinal Therapeutics Product
12.12.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca
12.13 Procter & Gamble
12.13.1 Company profile
12.13.2 Representative Gastrointestinal Therapeutics Product
12.13.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Procter & Gamble
12.14 Eisai
12.14.1 Company profile
12.14.2 Representative Gastrointestinal Therapeutics Product
12.14.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eisai
12.15 Shire Pharmaceuticals
12.15.1 Company profile
12.15.2 Representative Gastrointestinal Therapeutics Product
12.15.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Shire Pharmaceuticals
12.16 Ferring Pharmaceuticals
12.17 Kyowa Hakko Kirin
12.18 Salix Pharmaceuticals
12.19 Ono Pharmaceutical
12.20 TSD Japan
12.21 RedHill Biopharma
12.22 Kaken Pharmaceutical
12.23 Amgen
12.24 Synergy Pharmaceuticals
12.25 Ajinomoto
12.26 Kissei Pharmaceutical
12.27 Hutchison Medi Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL THERAPEUTICS
13.1 Industry Chain of Gastrointestinal Therapeutics
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL THERAPEUTICS
14.1 Cost Structure Analysis of Gastrointestinal Therapeutics
14.2 Raw Materials Cost Analysis of Gastrointestinal Therapeutics
14.3 Labor Cost Analysis of Gastrointestinal Therapeutics
14.4 Manufacturing Expenses Analysis of Gastrointestinal Therapeutics
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
